News
2h
Stocktwits on MSNGlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s WhyRetail chatter spiked last week as investors piled into three healthcare stocks: GlucoTrack, Sarepta Therapeutics, and TNF ...
The FDA is targeting ultraprocessed foods for reform to improve healthfulness of children's food. Whether the approach is comprehensive remains to be seen.
14h
The Western Journal on MSNGood News for Ice Cream Lovers: Key Manufacturers Make Big Health Vow Targeting 2028Robert F. Kennedy Jr.'s strategy as head of the Department of Health and Human Services is bearing fruit with regard to ice cream as various federal agencies announce that International Dairy Foods ...
Food and Drug Administration Commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss the MAHA push as major ...
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths - Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of i ...
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
Sarepta Therapeutics (NASDAQ:SRPT) shares dropped to a new 52-week low on Friday, triggering a trading halt after Bloomberg News reported that the FDA is reviewing whether the company’s gene therapy ...
Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its key gene therapy treatment appeared at risk. The Food and Drug Administration will request that the company ...
US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
2d
Axios on MSNFDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results